SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-233411
Filing Date
2014-06-11
Accepted
2014-06-11 16:19:59
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d726934d10q.htm 10-Q 745126
2 EX-31.1 d726934dex311.htm EX-31.1 8745
3 EX-32.1 d726934dex321.htm EX-32.1 4350
  Complete submission text file 0001193125-14-233411.txt   5135359

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT aldx-20140331.xml EX-101.INS 658529
5 XBRL TAXONOMY EXTENSION SCHEMA aldx-20140331.xsd EX-101.SCH 54744
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20140331_cal.xml EX-101.CAL 43551
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20140331_def.xml EX-101.DEF 226788
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20140331_lab.xml EX-101.LAB 416860
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20140331_pre.xml EX-101.PRE 307183
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 14904773
SIC: 2834 Pharmaceutical Preparations